Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin for delirium in hospitalized older adults
ACTRN12618000318280Phase 2Completed
- Sponsor
- A/Prof Gideon A Caplan
- Start
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in delirium comparing Intranasal insulin detemir with Intranasal saline placebo (2 arms). Primary endpoint: Duration of delirium. Started Mar 2018; status: completed.
02
Drugs
insulin detemir
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12618000318280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000318280.